Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3), abbreviated as MPP3, is a membrane-associated scaffold protein that belongs to the MAGUK (membrane-associated guanylate kinase homologs) family[1][3]. MAGUKs are key organizers of multiprotein complexes at intercellular junctions and regulate cellular architecture by interacting with the cytoskeleton. MPP3 contains a conserved SH3 domain and a catalytically inactive guanylate kinase (GK) domain, which play a crucial role in structural assembly and protein-protein interactions, especially in adherens junctions and signaling complexes[1][4]. MPP3 also interacts with the PI3K signaling pathway and contributes to cell spreading and stabilization of certain cell surface receptors[1]. While associated with intellectual disability and microdeletion syndromes, MPP3 is not currently a direct target for pharmacological intervention.
Not applicable; no pharmacological modulators or inhibitors are reported for MPP3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) (MPP3).